Suppr超能文献

基于证据的心房颤动心率控制药物治疗。

Evidenced-based pharmacotherapy for rate control in atrial fibrillation.

作者信息

Greenberg Heather

机构信息

Point Loma Nazarene University, San Diego, California 92040, USA.

出版信息

Crit Care Nurs Q. 2013 Apr-Jun;36(2):237-43. doi: 10.1097/CNQ.0b013e31828415dc.

Abstract

Atrial fibrillation is the most common arrhythmia found in older adults that places them at a high risk for stroke. The presence of AF in an individual, especially older than 60 years, increases the risk of mortality, affects quality of life, and increases prevalence of heart failure. The goal of AF treatment is to maintain heart rate or rhythm control and stroke prevention through anticoagulation. With appropriate management of AF an improvement of symptoms and a reduced morbidity from stroke or heart failure can be achieved. The best treatment for AF is prevention and early diagnosis.

摘要

心房颤动是老年人中最常见的心律失常,会使他们面临较高的中风风险。个体出现房颤,尤其是60岁以上的人,会增加死亡风险,影响生活质量,并增加心力衰竭的患病率。房颤治疗的目标是通过抗凝来维持心率或节律控制以及预防中风。通过对房颤进行适当管理,可以改善症状,并降低中风或心力衰竭的发病率。房颤的最佳治疗方法是预防和早期诊断。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验